The Vermont Cancer Center at the University of Vermont and Fletcher Allen Health Care will be hosting a public lecture on Thursday, June 26, 2014 from 5:30 to 6:30 p.m., titled “The Past, Present and Future in the Treatment of Acute Leukemia,” featuring Martin Tallman, MD, chief of the leukemia service at Memorial Sloan Kettering Cancer Center in New York. The event, which takes place in the Davis Auditorium in Fletcher Allen’s Ambulatory Care Center, West Pavilion Level 2, is free and open to the public.
Tallman’s presentation supports the Vermont Cancer Center’s mission to share – with the public, cancer providers, researchers, and health care experts – the latest information on cancer prevention and screening, diagnostics and treatment, as well as advances in clinical and laboratory research and issues of survivorship.
In addition to his public presentation, Tallman will spend a morning with oncology fellows at Fletcher Allen and deliver a professional lecture to faculty and staff at the Vermont Cancer Center on Friday, June 27, titled “Acute Myeloid Leukemia: Novel Therapeutic Strategies Based on a Changing Genetic Landscape.”
Tallman’s visit is made possible by the Sean Patrick Waldron Lymphoma and Hematologic Malignancies Fund at the Vermont Cancer Center. Created by Donna and Marty Waldron in 2011 and named in memory of their son Sean, who passed away in 1992 from leukemia, this unique fund supports innovative, life-saving lymphoma and leukemia research taking place in Vermont. It also enables the Vermont Cancer Center’s dedicated researchers and staff to grow and nurture patient and family-centered educational programs and prevention resources that serve the greater community.
Following the community lecture, Tallman will take questions from the audience about his presentation. For information about attending the event, contact Charles Brooks (Charles.Brooks@med.uvm.edu, or 802-656-4414) at the Vermont Cancer Center (RSVP not required, but encouraged). Refreshments will be served and parking is available in the Fletcher Allen parking garage.
Clinician investigators and basic scientists at the Vermont Cancer Center are involved in a number of research projects focused on understanding hematologic malignancies, advancing treatment for blood cancers, and reducing the burden of cancer on patients. The collaborative and interdisciplinary approach to research in areas such as leukemia has led to internally-funded program and pilot projects as well involvement in numerous clinical trials in the area of blood cancers and other hematologic malignancies. Tallman’s visit will bring the Vermont Cancer Center community together around this topic to generate new ideas to inform the innovative work being done here.
For more information about the Sean Patrick Waldron Lymphoma and Hematologic Malignancies Fund, contact Manon O’Connor (manon.oconnor@med.uvm.edu, or 802-656-4414), senior director for development at the Vermont Cancer Center.